Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1986.05.05 - 1986.05.21
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Well documented study essentially equivalent to standard test guidelines, although not to GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Isononyl alcohol
EC Number:
248-471-3
EC Name:
Isononyl alcohol
Cas Number:
27458-94-2
Molecular formula:
C9H20O
IUPAC Name:
3,5,5-trimethylhexan-1-ol
Details on test material:
- Name of test material (as cited in study report): Isononanol (C9 branched and linear)
- Physical state: liquid
- Analytical purity: > 99%
- Sample-No.: 3635-81058

Test animals

Species:
rat
Strain:
other: Ratte, Bor: WISW (SPF TNO)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: F. Winkelmann, 4799 Borchen
- Weight at study initiation: 116-119 g
- Fasting period before study: 16 hours
- Housing: 1 - 5 animals in "Makrolonkäfig" Type III
- Diet (e.g. ad libitum): R10 Alleindiät für Ratten, Ssniff Spezialfutter GmbH, 4770 Soest, ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 4 - 8 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20°C +- 1°C
- Humidity (%): 60% +-5%
- Air changes (per hr): 15 times/ hour
- Photoperiod (hrs dark / hrs light): 12 hrs dark/12hrs light

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
Single admistration by oral gavage (volume: 3.792-6.012 cm³/kg)
Doses:
3160 mg/kg, 3980 mg/kg and 5010 mg/kg
No. of animals per sex per dose:
5 males and 5 females per dose.
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Bodyweight: The animals were weighed before treatment and after 1, 7, and 14 days.
- Necropsy of survivors performed: yes
Statistics:
An LD50 was determined according to Litchfield and Wilcoxon including 95% confidence limits (J.Pharmacol. Exp. Ther. 96, 1949,99).

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 950 mg/kg bw
Mortality:
3160 mg/kg: 1/5 males and 1/5 females
3980 mg/kg: 1/5 males and 3/5 females
5010 mg/kg: 5/5 males and 4/5 females
Clinical signs:
other: 30 minutes after treatment, the animals showed ruffled fur, crouched posture, light tremor, temporary light sedation and ataxia with face-down position. Later, the following symptoms were also observed: decelerated and uncontrolled action, breathing diffi
Gross pathology:
Die Sektion am Versuchsende ergaben bei je 2 Tieren partielle Hyperämien der Dünndarmschleimhäute und herdförmige Verdickungen auf den Vormagenschleimhäuten. Eines dieser Tiere hatte außerdem eine hyperämische Magenschleimhaut.
Post mortem wurden bei den Sektionen Hyperämien der Magen- und Darmschleimhäute, hell gefleckte Lebern und bei einem Tier auch eine Hyperämie der Blasenschleimhaut festgestellt.

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Executive summary:

Isononanol (undiluted) was administered by oral gavage to three groups of 5 male and 5 female rats at dosages of 3160, 3980 or 5010 mg/kg. Shortly after administration, the animals showed ruffled fur, crouched posture, light tremor, temporary light sedation and ataxia with face-down position, followed by decelerated and uncontrolled action, breathing difficulties, semi-closed eyes, diarrhoea, hypothermia and lateral position. Deaths ocurred at all treatment levels. Symptoms were not apparent in surviving animals after Day 3 of the observation period, and bodyweights on Days 7 and 14 were unaffected. Necropsy findings were unremarkable.

The acute oral median lethal dossage (LD50 combined sexes) for Isononanol in rats was 3950 (confidence interval 3527-4424) mg/kg